Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Immuron Limited (DE:ANW)
FRANKFURT:ANW
Holding DE:ANW?
Track your performance easily
ANW Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.03 - €0.11
Previous Close€0.05
Volume0.00
Average Volume (3M)7.90K
Market Cap
€13.50M
Enterprise Value-€1.98M
Total Cash (Recent Filing)AU$17.16M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta-0.14
Next Earnings
Feb 26, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding227,798,346
10 Day Avg. Volume0
30 Day Avg. Volume7,900
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)0.57
Price to Sales (P/S)16.10
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-6.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Immuron Limited News
PremiumCompany Announcements
Immuron’s IMM-529 Eyes Phase 2 Trial for CDI Treatment
PremiumCompany Announcements
Immuron Limited Sees Revenue Surge Amid Rising R&D Costs
PremiumCompany Announcements
Immuron Limited CEO to Present at Biotech Event
PremiumCompany Announcements
Immuron Secures US Defense Grant to Advance TravelanOptions Prices
Currently, No data available
---
Ownership Overview
16.59% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
83.41% Public Companies and
Individual Investors
ANW FAQ
What was Immuron Limited’s price range in the past 12 months?
Immuron Limited lowest stock price was €0.03 and its highest was €0.11 in the past 12 months.
What is Immuron Limited’s market cap?
Currently, no data Available
When is Immuron Limited’s upcoming earnings report date?
Immuron Limited’s upcoming earnings report date is Feb 26, 2025 which is in 159 days.
How were Immuron Limited’s earnings last quarter?
Immuron Limited released its earnings results on Aug 30, 2024. The company reported -€0.013 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.013.
Is Immuron Limited overvalued?
According to Wall Street analysts Immuron Limited’s price is currently Overvalued.
Does Immuron Limited pay dividends?
Immuron Limited does not currently pay dividends.
What is Immuron Limited’s EPS estimate?
Immuron Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Immuron Limited have?
Immuron Limited has 227,998,350 shares outstanding.
What happened to Immuron Limited’s price movement after its last earnings report?
Immuron Limited reported an EPS of -€0.013 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Immuron Limited?
Currently, no hedge funds are holding shares in DE:ANW
---
Immuron Limited Stock Smart Score
Company Description
Immuron Limited
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
---
Technical Analysis
---